QHSLab

USAQ

Medical - Devices · Healthcare

Winston Score

Winston is serious

Mixed quality — meaningful strengths and weaknesses.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Mixed

Growth

Mixed

Cash Flow

Weak

Stability

Good

Valuation

Exceptional

Track this stock — start free trial

Winston Score History

The full picture

QHSLab, Inc. is a small healthcare company that sells tools and programs to help doctors monitor and improve their patients' health. Its main products are digital health assessments and wellness solutions sold directly to medical practices and healthcare providers across the United States. The company focuses on giving doctors easy-to-use software and testing kits so they can track things like nutrition, sleep, and overall wellness for their patients.

QHSLab makes money by selling its products and services to doctors and clinics, likely through a mix of product sales and recurring service fees. It operates entirely in the U.S. and is a very small company, with a market cap under $10 million. Its 66% gross margin suggests decent pricing power on its products, but its razor-thin operating margin means it has little room for error. The biggest risk the company faces is scaling up sales fast enough to survive as a tiny player competing against much larger digital health companies with bigger budgets and brand recognition.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+40.0% YoY

YoY Growth Rate

Strong revenue growth

EPS Growth

+153.2% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

48.1%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

5+ years

Quarterly Free Cash Flow

$317,392 cash & investments at current burn rate

Strong grower

QHSLab is growing revenue at 40% year-over-year. The Winston Score penalises unprofitable companies, but revenue at this pace tells a different story — this is a company still in "build mode."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

67.5%

Premium pricing power — 67.5% gross margin

Profit after running costs

Operating Margin

5.3%

Thin — 5.3% operating margin

Return on the money invested

ROCE

5.0%

Weak — 5.0% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+24.6%

Fast-growing sales (+24.6% YoY)

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

-20%

Weak — only -20% of profit becomes cash

Spare cash per sale

FCF Margin

-3.6%

Burning cash (-3.6%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.06

Conservative — low debt load (0.06)

Covers its interest

Interest Cover

0.68x

Dangerous — barely covers interest (0.7x)

Interest coverage below 1. Their profits don't cover the interest bill.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

6.3x

no trend

Attractive valuation — P/E 6.3

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year

P/E vs Forward

+5.6

GROWING

Earnings expected to grow meaningfully — cheaper on forward P/E (6.3 → 0.7)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial